Dimensional Fund Advisors’s Kaleido Biosciences, Inc. Common Stock KLDO Stock Holding History

Dimensional Fund Advisors’s Portfolio KLDO Stock Details KLDO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-10,484	Closed	-$17K	–	3590
2022 Q1	$17K	Hold	10,484	–	–	﹤0.01%	3505
2021 Q4	$25K	Hold	10,484	–	–	﹤0.01%	3524
2021 Q3	$57K	Buy	+10,484	New	+$65K	﹤0.01%	3464

Other funds holding KLDO

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

Dimensional Fund Advisors's KLDO Position: Q2 2022 in Review

Dimensional Fund Advisors sold out of Kaleido Biosciences, Inc. Common Stock (KLDO) in Q2 2022, closing a stake of 10,484 shares — an estimated $17K sold.

Dimensional Fund Advisors first reported a position in KLDO in Q3 2021 and held it in 3 quarters. The position peaked at $57K in Q3 2021. 3 funds tracked by Wall St. Rank hold KLDO as of Q2 2022.

Dimensional Fund Advisors reported no remaining Kaleido Biosciences, Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
Dimensional Fund Advisors sold 10,484 Kaleido Biosciences, Inc. Common Stock shares in Q2 2022, an estimated $17K.
Dimensional Fund Advisors first reported a position in Kaleido Biosciences, Inc. Common Stock in Q3 2021 and held it in 3 quarters.
Dimensional Fund Advisors's Kaleido Biosciences, Inc. Common Stock position peaked at $57K in Q3 2021.
3 funds tracked by Wall St. Rank held Kaleido Biosciences, Inc. Common Stock as of Q2 2022.

Based on Dimensional Fund Advisors's 13F filing for Q2 2022, filed 12 Aug 2022.